Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 6;11(23):eads3071.
doi: 10.1126/sciadv.ads3071. Epub 2025 Jun 6.

The SH protein of mumps virus is a druggable pentameric viroporin

Affiliations

The SH protein of mumps virus is a druggable pentameric viroporin

Kira Devantier et al. Sci Adv. .

Abstract

Viral infections are on the rise and drugs targeting viral proteins are needed. Viroporins constitute a growing group of virus-encoded transmembrane oligomeric proteins that allow passage of small molecules across the membrane. Despite sparsity in viroporin structures, recent work has revealed diversity in both the number of transmembrane helices and oligomeric states. Here, we provide evidence that the small hydrophobic protein (SH) from mumps virus is a pentameric viroporin. From extensive biophysical data, a HADDOCK model of full-length SH shows its intracellular C-terminal region to form an extended structure crucial to stabilization of the pentamer. Heterologous expression of wild-type SH and variants in Xenopus laevis oocytes reveals the viroporin as a chloride channel, with transport facilitated by conserved hydroxyl-carrying residues lining the pore. The channel function of SH is inhibited by the small-molecule BIT225, highlighting the potential for antiviral targeting through SH.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.. Oligomerization and structural characterization of SHFL.
(A) Consensus amino acid sequence of SH from genotype G. (B) Membrane topology of SH. (C) Left: SDS-PAGE of SHFL in 100 mM SDS. Right: SDS-PAGE of SHFL in 1:120 POPC. (D) Native MS of SHFL in DPC. (E) Far-UV CD spectrum of SHFL in 1:500 DHPC. (F) 1H-15N HSQC spectra of SHFL in different membrane mimetics and detergents as indicated. (G) SCS analysis of SHFL in 66% TFE:33% H2O (v/v). (H) 1H-15N HSQC spectra of the Trp51 indole peak from (F). Peaks colored by lipid or detergent head group charge. Anionic, red; Zwitterionic, blue.
Fig. 2.
Fig. 2.. SH is helical only in its TMD.
(A) 1H-15N HSQC spectrum of SH1–34 in 1:500 DHPC, with assignment. (B) SCS analysis of SH1–34 in (A). R1, R2, and HetNOE values for SH1–34 in 1:500 DHPC. (C) Far-UV CD spectra of SH1–34 in 1:500 DHPC. (D) 1H-15N HSQC spectrum of SH2–12, with assignment. (E) SCS analysis of SH2–12 in (D). (F) Far-UV CD spectra of SH2–12. (G) 1H-15N HSQC spectrum of SH39–57, with assignment. (H) SCS analysis of SH39–57 in (G). (I) Far-UV CD spectra of SH35–57.
Fig. 3.
Fig. 3.. The SH pentamer.
(A) Five helix bundle of the transmembrane region SH7-34. (B) Simplified two helix view of pore-lining residues and HOLE-calculated pore diameter. (C) Pore radius of SH7–34 along with pore-lining residues. (D) Examples of helix stabilizing residues in the helix-helix interface. (E) Clusters from MD simulation of SH35–57. (F) Two pentameric models of SHFL with extended C-termini. Insert: Zoom of Trp51 proximity to “membrane.”
Fig. 4.
Fig. 4.. SH is a viroporin and conducts Cl currents in Xenopus l. oocytes.
(A) Illustration of the two-electrode voltage clamp setup employed. One microelectrode is used for current injection, and one is used for voltage sensing, measuring the membrane potential (Vm) compared to a command voltage, which is leveled by an amplifier. (B) Summarized and averaged current-voltage (I/V) relations in SHFL-expressing oocytes compared to control (uninjected) oocytes. n = 11. (C) Current activity at −85 mV in SHFL-expressing oocytes compared to uninjected oocytes from (B). Inset: Representative current traces. (D) Summarized I/V curves of uninjected or with 4 or 50 ng of SHFL RNA/oocyte microinjected. n = 9. (E) Current activity at −85 mV in SHFL-expressing oocytes compared to uninjected oocytes from (D). (F) Summarized I/V curves of SHFL-induced currents in the presence or absence of Cl. n = 10. (G) Normalized data at Vm = −85 mV from (F). (H) Summarized I/V curves of SHFL-mediated currents in the presence or absence of Ca2+. n = 9. (I) Normalized data at Vm = −85 mV from (H). (J) Summarized I/V curves of SHFL-induced currents in the presence or absence of Na+. n = 7. (K) Normalized data at Vm = −85 mV from (J). All summarized current traces represent means ± SEM. Each point in the bar charts indicates an individual oocyte. The magnitude of SHFL-mediated currents (at Vm = −85 mV) was compared to those of uninjected oocytes using an unpaired t test (C), one-way analysis of variance (ANOVA) (E), or between the presence or absence of indicated ion with paired t test [(G), (I), and (K)]. *P < 0.033, **P < 0.002, and ***P < 0.001.
Fig. 5.
Fig. 5.. SH channel function is dependent on oligomerization and polar residues and inhibited by BIT225.
(A) Left: Schematic representation of SH variants. Right: Sequences of SH WT and variants. All electrophysiology experiments included a C-terminal His6-tag. SHLW: L24A, W27A. SHY: Y19A. (B) Summarized I/V curves of SH variants. n = 9,22. (C) Data at Vm = −85 mV from (B). (D) Surface side view of SHFL and SHLW. (E) Surface N-terminal view of SHFL and SHY. (F) Summarized I/V curves of SHFL-expressing oocytes with 45-min preincubation with 10 μM BIT225 or matched negative controls. n = 9. (G) Data at Vm = −85 mV from (F). (H) Concentration dependent inhibition of SHFL by BIT225. All summarized current traces represent means ± SEM. Each point in the bar charts indicates an individual oocyte. Statistical significance was determined with unpaired t test. *P < 0.033, **P < 0.002, and ***P < 0.001.

References

    1. Rubin S., Eckhaus M., Rennick L. J., Bamford C. G., Duprex W. P., Molecular biology, pathogenesis and pathology of mumps virus. J. Pathol. 235, 242–252 (2015). - PMC - PubMed
    1. Wu H., Wang F., Tang D., Han D., Mumps orchitis: Clinical aspects and mechanisms. Front. Immunol. 12, 582946 (2021). - PMC - PubMed
    1. Lau R. K., Turner M. D., Viral mumps: Increasing occurrences in the vaccinated population. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 128, 386–392 (2019). - PubMed
    1. Lam E., Rosen J. B., Zucker J. R., Mumps: An update on outbreaks, vaccine efficacy, and genomic diversity. Clin. Microbiol. Rev. 33, e00151-19 (2020). - PMC - PubMed
    1. Takeuchi K., Tanabayashi K., Hishiyama M., Yamada A., The mumps virus SH protein is a membrane protein and not essential for virus growth. Virology 225, 156–162 (1996). - PubMed

LinkOut - more resources